X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
https://www.prnewswire.com/news-releases/berkshire-biomedical-awarded-nih-research-grant-to-support-continued-development-of-the-copa-system-for-automated-at-home-methadone-administration-301592533.html
https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-martindale-pharma-an-ethypharm-group-company-methadone-5mg-tablets-slash-physeptone-5mg-tablets-el-21-a-slash-31
https://www.prnewswire.com/news-releases/relmada-therapeutics-announces-pricing-of-public-offering-of-common-stock-300968842.html
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/opioids-a-buprenorphine-methadone.html
https://www.prnewswire.com/news-releases/fda-approves-us-worldmeds-lucemyra-lofexidine-after-priority-review-for-the-management-of-opioid-withdrawal-symptoms-300649939.html
http://www.baltimoresun.com/health/bs-imodium-fda-opioid-addiction-20180321-story.html?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_source=hs_email&utm_medium=email&utm_content=61556079&_hsenc=p2ANqtz-9RdgM4OlvW2TsvoEWd4W_YW331kcBjJ2ABD8i-faccBrh8U_Pofz-2HmNAD_I2Mh2AIWhDrcprdst_2XohYU5tMvaTew&_hsmi=61556079
https://www.vox.com/policy-and-politics/2018/3/13/17020002/prison-opioid-epidemic-medications-addiction
http://www.nwaonline.com/news/2018/feb/26/fda-to-boost-drug-therapy-for-addicts-2/?news-national
https://www.prnewswire.com/news-releases/relmada-therapeutics-acquires-global-rights-to-develop-and-market-dextromethadone-for-treatment-of-disorders-of-the-nervous-system-300583736.html
https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm576755.htm
https://directorsblog.nih.gov/2017/05/31/all-scientific-hands-on-deck-to-end-the-opioid-crisis/
https://www.drugtargetreview.com/article/21644/ketamine-depression/
http://www.prnewswire.com/news-releases/relmada-announces-fda-acceptance-of-ind-and-authorization-to-commence-phase-2a-clinical-trial-for-d-methadone-300396997.html
http://www.prnewswire.com/news-releases/relmada-therapeutics-announces-results-of-in-vivo-study-showing-d-methadone-has-antidepressant-like-effects-300262537.html
http://www.reuters.com/article/us-health-hiv-drug-idUSKCN0XO2TM
http://www.forbes.com/sites/cjarlotta/2016/04/14/methadone-treatment-for-opioid-users-identifying-high-risk-of-relapse/#7e4718b5eabf
http://www.in-pharmatechnologist.com/Ingredients/Martindale-removes-povidone-in-oral-methadone-reformulation
http://www.prnewswire.com/news-releases/viiv-healthcare-announces-phase-ii-study-results-for-first-two-drug-long-acting-injectable-regimen-for-hiv-1-treatment-569850931.html
http://www.prnewswire.com/news-releases/relmada-therapeutics-receives-health-canada-clearance-to-commence-multiple-ascending-dose-study-with-promising-nmda-receptor-antagonist-300129056.html
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/006134Orig1s037ltr.pdf
http://www.biospace.com/News/use-of-methadone-to-treat-pain-ups-risk-of-death/361745/source=Featured
http://www.washingtonpost.com/local/a-drug-called-suboxone-could-combat-the-heroin-epidemic-so-why-is-it-so-hard-to-get/2015/01/13/4135d08c-812e-11e4-9f38-95a187e4c1f7_story.html
http://www.prnewswire.com/news-releases/relmada-therapeutics-successfully-completes-multiple-ascending-dose-study-of-d-methadone-for-neuropathic-pain-300198408.html
http://investor.sucampo.com/phoenix.zhtml?c=201197&p=irol-newsArticle&ID=2002365
Market Place
Share 
